The effects of transdermal methylphenidate with reference to OROS methylphenidate in ADHD

被引:0
|
作者
Lopez, Frank A. [1 ]
Shingler, Tarra [1 ]
Heinlein, Kristen [1 ]
机构
[1] Childrens Dev Ctr, Maitland, FL USA
来源
关键词
D O I
暂无
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
引用
收藏
页码:441 / 442
页数:2
相关论文
共 50 条
  • [1] Treatment of adolescent ADHD with OROS® methylphenidate
    McBurnett, K
    PEDIATRIC RESEARCH, 2003, 53 (04) : 555A - 555A
  • [2] Transdermal methylphenidate (Daytrana) for ADHD
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2006, 48 (1237): : 49 - 51
  • [3] Neurocognitive effects of switching from methylphenidate-IR to OROS-methylphenidate in children with ADHD
    Kim, Yeni
    Shin, Min-Sup
    Kim, Jae-Won
    Yoo, Hee-Jung
    Cho, Soo-Churl
    Kim, Boong-Nyun
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2009, 24 (02) : 95 - 102
  • [4] Optimizing methylphenidate delivery to improve treatment for ADHD:: Results with OROS® (methylphenidate HCl)
    Lerner, MA
    Modi, NB
    Gupta, S
    PEDIATRIC RESEARCH, 2000, 47 (04) : 29A - 29A
  • [5] Cardiovascular effects of the methylphenidate transdermal system in ADHD subjects
    Findling, R.
    Burnside, J.
    Boellner, S.
    Cohen, J.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 231 - 231
  • [6] Parent rated effects of transdermal methylphenidate in children with ADHD
    Wigal, S.
    Turnbow, J.
    Abikoff, H.
    McGough, J.
    Cohen, J.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 232 - 232
  • [7] Behavioral effects of methylphenidate transdermal system in children with ADHD
    Lopez, Frank A.
    Shingler, Tarra
    Heinlein, Kristen
    JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 2006, 27 (05): : 441 - 441
  • [8] Comparison of the impact of OROS methylphenidate HCI with methylphenidate tid and placebo on the sleep of children with ADHD
    Swanson, J
    Sadeh, A
    Lerner, MA
    Wigal, SB
    JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 2000, 21 (05): : 387 - 388
  • [9] Effects of OROS methylphenidate (OROS MPH) treatment in children and adolescents with ADHD, mental retardation and epilepsy
    Kesic, A.
    Lakic, A.
    Dronjak, D.
    Stupar, D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S420 - S421
  • [10] Comparison of the efficacy and safety of OROS® methylphenidate HCl with methylphenidate tid and placebo in children with ADHD
    Swanson, JM
    Wigal, SB
    Lerner, MA
    PEDIATRIC RESEARCH, 2000, 47 (04) : 34A - 34A